Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-23

Clinical Trial Update: A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND} [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sertraline to cognitive behavioral therapy for depression in patients with end-stage renal disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cognitive behavioral therapy
  • Sertraline (Sertraline)

Snippet

Sponsor: University of Washington | Conditions: Depression, End Stage Renal Disease | Phase 3 | Status: COMPLETED | Results posted: 2019-07-23